Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proto-Oncogene Proteins c-ets | 8 | 2016 | 314 | 0.540 |
Why?
|
Proteomics | 7 | 2024 | 3845 | 0.490 |
Why?
|
Phenylketonurias | 1 | 2005 | 126 | 0.220 |
Why?
|
Phenylalanine | 1 | 2005 | 366 | 0.220 |
Why?
|
Proto-Oncogene Proteins | 8 | 2016 | 4510 | 0.220 |
Why?
|
Eosinophilic Esophagitis | 1 | 2024 | 192 | 0.190 |
Why?
|
NF-kappa B | 6 | 2011 | 2488 | 0.180 |
Why?
|
Purkinje Cells | 2 | 2013 | 226 | 0.170 |
Why?
|
Fanconi Anemia | 1 | 2022 | 324 | 0.170 |
Why?
|
Capillary Leak Syndrome | 1 | 2019 | 34 | 0.170 |
Why?
|
Salivary Cystatins | 1 | 2018 | 11 | 0.160 |
Why?
|
Peroxiredoxins | 1 | 2018 | 51 | 0.160 |
Why?
|
Neutrophil Activation | 1 | 2019 | 180 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-jun | 2 | 2011 | 285 | 0.150 |
Why?
|
Blood Proteins | 2 | 2024 | 1180 | 0.150 |
Why?
|
Ileum | 1 | 2020 | 557 | 0.150 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2018 | 138 | 0.150 |
Why?
|
Esophagus | 1 | 2024 | 1031 | 0.150 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2016 | 8545 | 0.150 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2018 | 284 | 0.150 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2020 | 314 | 0.150 |
Why?
|
Receptor, TIE-2 | 1 | 2018 | 176 | 0.140 |
Why?
|
Specimen Handling | 1 | 2022 | 702 | 0.140 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2018 | 187 | 0.140 |
Why?
|
Aptamers, Nucleotide | 1 | 2018 | 165 | 0.140 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2016 | 2871 | 0.140 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2020 | 326 | 0.140 |
Why?
|
Cyclin D3 | 1 | 2016 | 54 | 0.130 |
Why?
|
Facial Transplantation | 1 | 2018 | 221 | 0.130 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2016 | 58 | 0.130 |
Why?
|
Cell Cycle Proteins | 4 | 2016 | 3447 | 0.120 |
Why?
|
Transcription, Genetic | 8 | 2012 | 7595 | 0.120 |
Why?
|
Pentamidine | 1 | 2014 | 44 | 0.120 |
Why?
|
Metformin | 1 | 2022 | 906 | 0.120 |
Why?
|
Gene Expression Regulation | 4 | 2010 | 11902 | 0.120 |
Why?
|
Apoptosis | 10 | 2016 | 9488 | 0.120 |
Why?
|
Nasal Cavity | 1 | 2016 | 304 | 0.110 |
Why?
|
Exosomes | 1 | 2018 | 424 | 0.110 |
Why?
|
Transcription Factors | 8 | 2008 | 12125 | 0.110 |
Why?
|
Gene Expression Profiling | 4 | 2010 | 9418 | 0.110 |
Why?
|
Metabolome | 1 | 2020 | 987 | 0.110 |
Why?
|
Nasal Polyps | 1 | 2018 | 395 | 0.110 |
Why?
|
Prostatic Neoplasms | 4 | 2016 | 11118 | 0.110 |
Why?
|
Hepatolenticular Degeneration | 2 | 2004 | 72 | 0.110 |
Why?
|
Signal Transduction | 9 | 2018 | 23441 | 0.110 |
Why?
|
Fatty Acids | 1 | 2020 | 1808 | 0.100 |
Why?
|
Cerebellar Cortex | 1 | 2013 | 107 | 0.100 |
Why?
|
Nuclear Proteins | 5 | 2016 | 5794 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2298 | 0.100 |
Why?
|
DNA-Binding Proteins | 6 | 2008 | 9606 | 0.090 |
Why?
|
Serine-Type D-Ala-D-Ala Carboxypeptidase | 1 | 2010 | 16 | 0.090 |
Why?
|
Rhinitis | 1 | 2018 | 747 | 0.090 |
Why?
|
Serine Endopeptidases | 1 | 2016 | 1021 | 0.090 |
Why?
|
Exocrine Glands | 1 | 2010 | 46 | 0.090 |
Why?
|
Cation Transport Proteins | 2 | 2004 | 327 | 0.090 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2010 | 55 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2016 | 546 | 0.090 |
Why?
|
Pyloric Antrum | 1 | 2010 | 66 | 0.090 |
Why?
|
Boronic Acids | 3 | 2005 | 915 | 0.090 |
Why?
|
Pyrroles | 1 | 2016 | 1125 | 0.080 |
Why?
|
Hydroxamic Acids | 1 | 2012 | 481 | 0.080 |
Why?
|
Sinusitis | 1 | 2018 | 991 | 0.080 |
Why?
|
Endothelium, Vascular | 2 | 2019 | 4430 | 0.080 |
Why?
|
Adenosine Triphosphatases | 2 | 2004 | 834 | 0.080 |
Why?
|
Pyrazines | 3 | 2005 | 1201 | 0.080 |
Why?
|
Up-Regulation | 5 | 2018 | 4124 | 0.080 |
Why?
|
Cerebral Cortex | 1 | 2005 | 5776 | 0.080 |
Why?
|
Mucus | 1 | 2010 | 341 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4320 | 0.080 |
Why?
|
Integrin beta3 | 1 | 2008 | 120 | 0.070 |
Why?
|
Indoles | 1 | 2016 | 1832 | 0.070 |
Why?
|
Dendrites | 1 | 2010 | 475 | 0.070 |
Why?
|
Collagen Type II | 1 | 2008 | 148 | 0.070 |
Why?
|
Tissue Plasminogen Activator | 1 | 2013 | 1164 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2024 | 3810 | 0.070 |
Why?
|
Epigenomics | 1 | 2012 | 942 | 0.070 |
Why?
|
Transfection | 4 | 2008 | 5775 | 0.070 |
Why?
|
Interleukins | 2 | 2011 | 782 | 0.070 |
Why?
|
Promoter Regions, Genetic | 6 | 2008 | 5789 | 0.070 |
Why?
|
GTP-Binding Proteins | 1 | 2010 | 951 | 0.070 |
Why?
|
Calcification, Physiologic | 1 | 2006 | 170 | 0.060 |
Why?
|
Shock, Septic | 1 | 2012 | 768 | 0.060 |
Why?
|
Transcriptional Activation | 3 | 2007 | 1756 | 0.060 |
Why?
|
Rifabutin | 1 | 2005 | 59 | 0.060 |
Why?
|
Sialoglycoproteins | 1 | 2006 | 316 | 0.060 |
Why?
|
Neurons | 1 | 2005 | 9462 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2010 | 3779 | 0.060 |
Why?
|
Graft Rejection | 1 | 2018 | 4445 | 0.060 |
Why?
|
Trans-Activators | 2 | 2006 | 2856 | 0.060 |
Why?
|
Chondrocytes | 2 | 2008 | 795 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 2 | 2014 | 3163 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2016 | 1726 | 0.060 |
Why?
|
RNA, Small Interfering | 3 | 2011 | 3428 | 0.060 |
Why?
|
Enzyme Induction | 1 | 2005 | 452 | 0.060 |
Why?
|
Osteoclasts | 1 | 2008 | 711 | 0.060 |
Why?
|
Bone Resorption | 1 | 2008 | 723 | 0.060 |
Why?
|
Lipopolysaccharides | 3 | 2012 | 2207 | 0.060 |
Why?
|
Cell Division | 3 | 2006 | 4466 | 0.060 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 318 | 0.060 |
Why?
|
Mesoderm | 1 | 2007 | 673 | 0.060 |
Why?
|
Neurotoxins | 1 | 2005 | 240 | 0.060 |
Why?
|
Thrombosis | 1 | 2018 | 2942 | 0.060 |
Why?
|
Cell Movement | 1 | 2016 | 5203 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2585 | 0.060 |
Why?
|
Cell Line, Tumor | 7 | 2011 | 16979 | 0.060 |
Why?
|
Oligonucleotides | 2 | 2023 | 582 | 0.060 |
Why?
|
Osteoblasts | 2 | 2006 | 1143 | 0.050 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2023 | 72 | 0.050 |
Why?
|
Angiopoietin-1 | 1 | 2004 | 122 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2011 | 3602 | 0.050 |
Why?
|
Epithelial Cells | 2 | 2007 | 3667 | 0.050 |
Why?
|
Multiple Myeloma | 4 | 2005 | 5146 | 0.050 |
Why?
|
Cell Adhesion | 2 | 2007 | 3087 | 0.050 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2005 | 424 | 0.050 |
Why?
|
Integrins | 1 | 2007 | 834 | 0.050 |
Why?
|
Interleukin-1 | 2 | 2003 | 1249 | 0.050 |
Why?
|
RNA, Messenger | 6 | 2012 | 12796 | 0.050 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2002 | 188 | 0.050 |
Why?
|
Skull | 1 | 2006 | 818 | 0.050 |
Why?
|
Male | 20 | 2024 | 360736 | 0.050 |
Why?
|
Humans | 36 | 2024 | 761423 | 0.050 |
Why?
|
Ovarian Neoplasms | 2 | 2011 | 4876 | 0.050 |
Why?
|
src-Family Kinases | 1 | 2004 | 535 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2011 | 2273 | 0.050 |
Why?
|
Swine Diseases | 1 | 2020 | 61 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2016 | 7856 | 0.050 |
Why?
|
Animals | 17 | 2020 | 168441 | 0.040 |
Why?
|
DNA Damage | 3 | 2006 | 2446 | 0.040 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2004 | 487 | 0.040 |
Why?
|
Tumor Cells, Cultured | 4 | 2016 | 6132 | 0.040 |
Why?
|
Synovial Membrane | 1 | 2003 | 532 | 0.040 |
Why?
|
Mice | 13 | 2018 | 81509 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2024 | 22168 | 0.040 |
Why?
|
Osteogenesis | 1 | 2006 | 1273 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4575 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2007 | 1960 | 0.040 |
Why?
|
Respiratory Mucosa | 1 | 2002 | 439 | 0.040 |
Why?
|
Glutamic Acid | 1 | 2005 | 1176 | 0.040 |
Why?
|
Monocytes | 2 | 2006 | 2572 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2010 | 18964 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2002 | 666 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 2002 | 753 | 0.040 |
Why?
|
Neoplasm Invasiveness | 1 | 2007 | 3589 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2022 | 675 | 0.040 |
Why?
|
Drug Synergism | 3 | 2011 | 1755 | 0.040 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2003 | 774 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6339 | 0.040 |
Why?
|
Fatty Liver | 1 | 2024 | 789 | 0.040 |
Why?
|
Antineoplastic Agents | 5 | 2016 | 13637 | 0.040 |
Why?
|
Adult | 12 | 2024 | 221148 | 0.040 |
Why?
|
RNA Interference | 3 | 2011 | 2831 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5365 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9277 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2004 | 4354 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15262 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2022 | 20093 | 0.040 |
Why?
|
Mice, Knockout | 4 | 2018 | 14409 | 0.040 |
Why?
|
Angiopoietin-2 | 1 | 2018 | 172 | 0.040 |
Why?
|
Female | 16 | 2024 | 392581 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2011 | 11740 | 0.030 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2011 | 441 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2018 | 2706 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2007 | 3490 | 0.030 |
Why?
|
Parenteral Nutrition | 1 | 2020 | 659 | 0.030 |
Why?
|
Transduction, Genetic | 2 | 2010 | 902 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2024 | 39117 | 0.030 |
Why?
|
Middle Aged | 9 | 2024 | 220826 | 0.030 |
Why?
|
Blotting, Western | 3 | 2011 | 5036 | 0.030 |
Why?
|
Cell Survival | 3 | 2013 | 5790 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2016 | 225 | 0.030 |
Why?
|
Cell Differentiation | 5 | 2013 | 11526 | 0.030 |
Why?
|
Protein Stability | 1 | 2016 | 578 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2006 | 3396 | 0.030 |
Why?
|
Mice, SCID | 2 | 2011 | 2626 | 0.030 |
Why?
|
Nose Neoplasms | 1 | 2016 | 249 | 0.030 |
Why?
|
Antiprotozoal Agents | 1 | 2014 | 94 | 0.030 |
Why?
|
Down-Regulation | 3 | 2006 | 2918 | 0.030 |
Why?
|
Mice, Neurologic Mutants | 1 | 2013 | 107 | 0.030 |
Why?
|
Fibrinolysin | 1 | 2013 | 131 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2011 | 3597 | 0.030 |
Why?
|
Rats | 2 | 2006 | 23742 | 0.030 |
Why?
|
Immunohistochemistry | 4 | 2008 | 11073 | 0.020 |
Why?
|
Sulindac | 1 | 2011 | 29 | 0.020 |
Why?
|
Fasting | 1 | 2018 | 1602 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2011 | 73 | 0.020 |
Why?
|
Diclofenac | 1 | 2011 | 68 | 0.020 |
Why?
|
Exons | 2 | 2010 | 2393 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2014 | 749 | 0.020 |
Why?
|
Mucin-6 | 1 | 2010 | 15 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 2 | 2004 | 3755 | 0.020 |
Why?
|
DNA Mutational Analysis | 3 | 2004 | 4110 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2004 | 1992 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2006 | 3613 | 0.020 |
Why?
|
Swine | 1 | 2020 | 5914 | 0.020 |
Why?
|
Sesquiterpenes | 1 | 2011 | 176 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2004 | 4764 | 0.020 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2010 | 127 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2016 | 791 | 0.020 |
Why?
|
Logistic Models | 1 | 2024 | 13255 | 0.020 |
Why?
|
Proteins | 1 | 2004 | 6032 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2013 | 22163 | 0.020 |
Why?
|
Prognosis | 3 | 2018 | 29620 | 0.020 |
Why?
|
Mutation | 6 | 2016 | 30045 | 0.020 |
Why?
|
Nerve Tissue Proteins | 2 | 2012 | 4414 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2005 | 4248 | 0.020 |
Why?
|
Proteome | 1 | 2018 | 1862 | 0.020 |
Why?
|
Fibroblasts | 3 | 2004 | 4140 | 0.020 |
Why?
|
Premature Birth | 1 | 2020 | 1782 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2010 | 794 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 687 | 0.020 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2008 | 63 | 0.020 |
Why?
|
Base Sequence | 2 | 2012 | 12450 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7238 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2008 | 293 | 0.020 |
Why?
|
Mice, Nude | 1 | 2014 | 3614 | 0.020 |
Why?
|
Hyperplasia | 1 | 2010 | 1152 | 0.020 |
Why?
|
Mucins | 1 | 2010 | 568 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2005 | 17644 | 0.020 |
Why?
|
Neurogenesis | 1 | 2013 | 862 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6766 | 0.020 |
Why?
|
Neutrophils | 1 | 2019 | 3766 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2019 | 3541 | 0.020 |
Why?
|
Risk Assessment | 2 | 2024 | 23990 | 0.020 |
Why?
|
Nerve Degeneration | 1 | 2010 | 748 | 0.020 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2006 | 158 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2008 | 878 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 615 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1967 | 0.020 |
Why?
|
Gene Expression | 2 | 2012 | 7584 | 0.020 |
Why?
|
Tumor Burden | 1 | 2011 | 1890 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2006 | 6086 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2005 | 2455 | 0.020 |
Why?
|
Cell Line | 3 | 2004 | 15605 | 0.020 |
Why?
|
raf Kinases | 1 | 2005 | 118 | 0.020 |
Why?
|
Phosphorus | 1 | 2006 | 336 | 0.020 |
Why?
|
Benzoquinones | 1 | 2005 | 198 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2010 | 1154 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2010 | 2677 | 0.020 |
Why?
|
Phenotype | 3 | 2012 | 16606 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2008 | 558 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8320 | 0.020 |
Why?
|
Disease Progression | 2 | 2016 | 13502 | 0.010 |
Why?
|
Culture Media | 1 | 2006 | 896 | 0.010 |
Why?
|
Osteopontin | 1 | 2006 | 301 | 0.010 |
Why?
|
Granulocytes | 1 | 2006 | 552 | 0.010 |
Why?
|
Aged | 4 | 2024 | 169235 | 0.010 |
Why?
|
I-kappa B Kinase | 1 | 2005 | 250 | 0.010 |
Why?
|
Cartilage | 1 | 2008 | 806 | 0.010 |
Why?
|
Receptors, Interleukin-6 | 1 | 2005 | 225 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6215 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2008 | 2265 | 0.010 |
Why?
|
Inflammation | 1 | 2004 | 10762 | 0.010 |
Why?
|
Lactams, Macrocyclic | 1 | 2005 | 318 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2004 | 211 | 0.010 |
Why?
|
Young Adult | 2 | 2022 | 59207 | 0.010 |
Why?
|
Leukemia, B-Cell | 1 | 2004 | 84 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9320 | 0.010 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2005 | 431 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 2006 | 864 | 0.010 |
Why?
|
Receptor, IGF Type 1 | 1 | 2005 | 379 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2004 | 815 | 0.010 |
Why?
|
Cerebellum | 1 | 2010 | 1500 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2005 | 389 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 2003 | 417 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2003 | 330 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2004 | 17912 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2006 | 1900 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2005 | 597 | 0.010 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2002 | 145 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2010 | 1878 | 0.010 |
Why?
|
Interleukin-1beta | 1 | 2008 | 997 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 321 | 0.010 |
Why?
|
Ovariectomy | 1 | 2004 | 614 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1879 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2006 | 1827 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2004 | 671 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2012 | 18247 | 0.010 |
Why?
|
Luciferases | 1 | 2004 | 714 | 0.010 |
Why?
|
COS Cells | 1 | 2004 | 1130 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2004 | 750 | 0.010 |
Why?
|
Cohort Studies | 1 | 2024 | 41446 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 618 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3201 | 0.010 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2004 | 359 | 0.010 |
Why?
|
Protein Binding | 2 | 2004 | 9352 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 1545 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2011 | 3207 | 0.010 |
Why?
|
3T3 Cells | 1 | 2002 | 1085 | 0.010 |
Why?
|
Melphalan | 1 | 2002 | 420 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15650 | 0.010 |
Why?
|
Chemotaxis | 1 | 2004 | 599 | 0.010 |
Why?
|
Cattle | 1 | 2006 | 3848 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2012 | 3823 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2004 | 1693 | 0.010 |
Why?
|
Motor Activity | 1 | 2010 | 2711 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 12951 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10441 | 0.010 |
Why?
|
Child | 3 | 2022 | 80162 | 0.010 |
Why?
|
Neoplasm Staging | 2 | 2005 | 11106 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2003 | 1706 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2002 | 551 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2004 | 1529 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54415 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 2748 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1246 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1626 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2003 | 1062 | 0.010 |
Why?
|
Homeostasis | 1 | 2010 | 3321 | 0.010 |
Why?
|
Aging | 1 | 2018 | 8705 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2004 | 1699 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2004 | 988 | 0.010 |
Why?
|
Estrogens | 1 | 2005 | 1522 | 0.010 |
Why?
|
Plasmids | 1 | 2004 | 2269 | 0.010 |
Why?
|
Genotype | 2 | 2004 | 13009 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 2820 | 0.010 |
Why?
|
Bronchi | 1 | 2002 | 845 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2002 | 926 | 0.010 |
Why?
|
Heat-Shock Proteins | 1 | 2002 | 796 | 0.010 |
Why?
|
Peptides | 1 | 2010 | 4345 | 0.010 |
Why?
|
Collagen | 1 | 2006 | 2638 | 0.010 |
Why?
|
Protein Transport | 1 | 2004 | 1966 | 0.010 |
Why?
|
Androgens | 1 | 2005 | 1286 | 0.010 |
Why?
|
Oncogenes | 1 | 2003 | 1222 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2010 | 9535 | 0.010 |
Why?
|
Ubiquitin | 1 | 2002 | 839 | 0.010 |
Why?
|
Bone and Bones | 1 | 2008 | 2568 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 3792 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2006 | 2824 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2114 | 0.010 |
Why?
|
United States | 1 | 2024 | 72339 | 0.010 |
Why?
|
Chromatin | 1 | 2008 | 2960 | 0.010 |
Why?
|
Gene Deletion | 1 | 2004 | 2667 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2002 | 1320 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10766 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2004 | 3514 | 0.010 |
Why?
|
Doxorubicin | 1 | 2002 | 2224 | 0.010 |
Why?
|
Gene Frequency | 1 | 2003 | 3647 | 0.010 |
Why?
|
Leukemia | 1 | 2004 | 1522 | 0.010 |
Why?
|
Neoplasms | 1 | 2004 | 22164 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 8179 | 0.010 |
Why?
|
Osteoarthritis | 1 | 2003 | 1060 | 0.010 |
Why?
|
Binding Sites | 1 | 2004 | 6055 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2005 | 2557 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2002 | 1931 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2016 | 64651 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2005 | 4912 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2004 | 3395 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74167 | 0.010 |
Why?
|
Calcium | 1 | 2006 | 5727 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 8529 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13449 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9469 | 0.010 |
Why?
|
Survival Analysis | 1 | 2004 | 10089 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2003 | 4741 | 0.010 |
Why?
|
Child, Preschool | 2 | 2004 | 42254 | 0.010 |
Why?
|
Recurrence | 1 | 2002 | 8469 | 0.010 |
Why?
|
DNA | 1 | 2004 | 7219 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2004 | 14664 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 39975 | 0.000 |
Why?
|
Cytokines | 1 | 2004 | 7392 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36423 | 0.000 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2006 | 5670 | 0.000 |
Why?
|
Macrophages | 1 | 2003 | 5768 | 0.000 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2002 | 5305 | 0.000 |
Why?
|
Adolescent | 2 | 2004 | 88313 | 0.000 |
Why?
|